The Mauritanian government has approved a decree to regulate drug promotion and advertising in the country. The decree, approved on Wednesday, aims to establish rules for the promotion of drugs for human use, directed at healthcare professionals and the general public. It also regulates the activities of medical representatives and outlines procedures for obtaining necessary licenses to practice promotional and medical information activities.
The decree, numbered 2025-042 and issued on November 26, 2025, is part of a broader effort to review and update the 2010 law on pharmacy. The goal is to complete the regulatory framework for the sector and establish clear legal controls for various activities related to drugs and cosmetic products. This move is expected to enhance oversight of products in the market and ensure adherence to quality and safety standards.
The new decree outlines specific rules for drug promotion, including conditions for advertising to the public and to healthcare professionals. It also sets out procedures for the prior authorization of promotional activities and medical information. These measures are designed to ensure that promotional activities are conducted in a transparent and controlled manner.
In addition to regulating drug promotion, the decree also addresses the manufacture, importation, storage, distribution, and dispensing of cosmetic products and body hygiene products. It establishes a framework for monitoring the quality of these products, which is expected to improve public health and safety.
The Mauritanian government's decision to approve this decree reflects its commitment to strengthening the regulatory environment for the pharmaceutical sector. By establishing clear rules and guidelines for drug promotion and advertising, the government aims to promote a more transparent and accountable market.
The decree is also expected to have a positive impact on the country's healthcare system, as it seeks to ensure that healthcare professionals and the general public have access to accurate and reliable information about medicines. This, in turn, is likely to lead to better health outcomes and improved patient care.
Overall, the approval of this decree marks an important step towards enhancing the regulation of the pharmaceutical sector in Mauritania. The government's efforts to establish a more robust regulatory framework are likely to have a positive impact on public health and safety, as well as the overall quality of healthcare services in the country.
Key points
- The decree aims to establish clear rules for drug promotion and advertising in Mauritania.
- The decree is part of a broader effort to review and update the 2010 law on pharmacy.
- The decree seeks to ensure that promotional activities are conducted in a transparent and controlled manner.
Reporting sources
- موريتانيا تصادق على مرسوم لتحديد شروط ترويج الأدوية · saharamedias.net